Literature DB >> 29705834

Improved Magnesium Levels in Morbidly Obese Diabetic and Non-diabetic Patients After Modest Weight Loss.

Solveig Meyer Mikalsen1, Anne-Lise Bjørke-Monsen2,3, Jon Elling Whist4,5, Jan Aaseth5,6.   

Abstract

Serum magnesium (Mg) is reported to be reduced in individuals with obesity, hypertension, and diabetes mellitus and has been suggested as a marker for metabolic syndrome. We have studied changes in serum Mg concentrations in a group of obese patients (n = 92) with and without diabetes mellitus after weight loss induced by dieting and bariatric surgery. At inclusion, 11% (10/92) of the population had severe Mg deficiency (< 0.75 mmol/L) and median serum Mg was lower in diabetic (n = 20) compared to non-diabetic (n = 72) patients (p = 0.002). A weight loss of 10 kg after 8 weeks of lifestyle interventions was accompanied by increased serum Mg of about 5% in both diabetic and non-diabetic patients. Serum Mg remained stable thereafter in the non-diabetic patients, while it continued to increase in the diabetic patients after bariatric surgery. Six months after bariatric surgery, there was no significant difference in serum Mg concentration between the groups (p = 0.08). The optimal range of circulating Mg concentration is not known, but as even small increments in serum Mg are reported to lower the risk of cardiovascular and ischemic heart disease, our results are interesting in a public health perspective.

Entities:  

Keywords:  Bariatric surgery; Diabetes mellitus; Magnesium; Metabolic syndrome; Obesity; Weight loss

Mesh:

Substances:

Year:  2018        PMID: 29705834     DOI: 10.1007/s12011-018-1349-3

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  2 in total

1.  Differences in Serum Magnesium Levels in Diabetic and Non-Diabetic Patients Following One-Anastomosis Gastric Bypass.

Authors:  Eva Winzer; Igor Grabovac; Bernhard Ludvik; Renate Kruschitz; Karin Schindler; Gerhard Prager; Carmen Klammer; Lee Smith; Friedrich Hoppichler; Rodrig Marculescu; Maria Wakolbinger
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

2.  High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes.

Authors:  Langen Zhuang; Can Li; Xiaolei Hu; Qingqing Yang; Xiaoyan Pei; Guoxi Jin
Journal:  Braz J Med Biol Res       Date:  2022-08-15       Impact factor: 2.904

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.